Consumer demand for GLP-1 drugs like Ozempic and Wegovy has drawn a flood of new entrants. Yaccarino will have to find a way ...

Aon plc (NYSE: AON), a leading global professional services firm, today announced a strategic investment in eMed Population ...

Aon has invested in eMed Population Health, a provider of GLP-1 programs, to expand employer-sponsored access to GLP-1 ...

Though Yaccarino does not have experience in health tech, eMed said in a press release that they sought her out for her ...

Linda Yaccarino is taking the top job at eMed Population Health, a telehealth startup focused on GLP-1 weight loss drugs, ...

Former X CEO Linda Yaccarino has been tapped as the new CEO of eMed Population Health, an AI‑driven health tech startup.

Yaccarino will be CEO of a unit at the company, which focuses on patients taking weight-management and diabetes medications.

Linda Yaccarino, less than a month after stepping down as CEO of Elon Musk’s X, has found her next gig. Yaccarino has been ...

Digital health platform eMed Population Health said on Tuesday it has appointed Linda Yaccarino, the former CEO of social media site X, as its chief executive officer.

The eMed Population Health digital health platform announced Tuesday that former X Chief Executive Officer Linda Yaccarino has been appointed its new CEO.

Med Population Health, the leading digital health platform for GLP-1/GIP population health management, today announced the appointment of Linda Yaccarino, former CEO of X (Twitter), as the company's ...